196 related articles for article (PubMed ID: 25833691)
1. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.
Chang Y; Wu Q; Tian T; Li L; Guo X; Feng Z; Zhou J; Zhang L; Zhou S; Feng G; Han F; Yang J; Huang F
Tumour Biol; 2015 Aug; 36(8):6083-93. PubMed ID: 25833691
[TBL] [Abstract][Full Text] [Related]
2. Plexin-B1 indirectly affects glioma invasiveness and angiogenesis by regulating the RhoA/αvβ3 signaling pathway and SRPK1.
Chang Y; Li L; Zhang L; Guo X; Feng Z; Zhou J; Zhou S; Feng G; Han F; Huang W; Yang J; Huang F
Tumour Biol; 2016 Aug; 37(8):11225-36. PubMed ID: 26944058
[TBL] [Abstract][Full Text] [Related]
3. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
[TBL] [Abstract][Full Text] [Related]
4. SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K/Akt signaling pathway in a rat model of intracranial aneurysms.
Li XG; Wang YB
CNS Neurosci Ther; 2019 Feb; 25(2):233-244. PubMed ID: 30101479
[TBL] [Abstract][Full Text] [Related]
5. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.
Zhu Y; Zhang X; Qi L; Cai Y; Yang P; Xuan G; Jiang Y
Oncotarget; 2016 Mar; 7(12):14429-40. PubMed ID: 26894862
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Serine-Arginine Protein Kinase 1 Inhibits the Growth and Migration in Renal Cell Carcinoma Cells.
Han X; Yang J; Jia Z; Wei P; Zhang H; Lv W; Sun J; Huo Q
Oncol Res; 2017 Mar; 25(3):389-395. PubMed ID: 27662590
[TBL] [Abstract][Full Text] [Related]
8. A HIF1A/miR-485-5p/SRPK1 axis modulates the aggressiveness of glioma cells upon hypoxia.
Cheng L; Peng R; Guo P; Zhang H; Liu D; Liao X; Liu Y; Mo X; Liao Y
Exp Cell Res; 2021 May; 402(1):112547. PubMed ID: 33722639
[TBL] [Abstract][Full Text] [Related]
9. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
10. Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.
Peng R; Jiang B; Ma J; Ma Z; Wan X; Liu H; Chen Z; Cheng Q; Chen R
Oncol Rep; 2013 Nov; 30(5):2195-202. PubMed ID: 24008630
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway.
Gao S; Jin L; Liu G; Wang P; Sun Z; Cao Y; Shi H; Liu X; Shi Q; Zhou X; Yu R
Sci Rep; 2017 Jun; 7(1):3202. PubMed ID: 28600528
[TBL] [Abstract][Full Text] [Related]
12. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
13. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
[TBL] [Abstract][Full Text] [Related]
14. BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas.
Gao S; Sha Z; Zhou J; Wu Y; Song Y; Li C; Liu X; Zhang T; Yu R
Cancer Biol Med; 2021 Feb; 18(1):88-104. PubMed ID: 33628587
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells.
Liu H; Hu X; Zhu Y; Jiang G; Chen S
Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824
[TBL] [Abstract][Full Text] [Related]
16. Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma.
Di J; Gao K; Qu D; Yang J; Zheng J
Tumour Biol; 2017 Jul; 39(7):1010428317701653. PubMed ID: 28691643
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
19. Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway.
Zhao KH; Zhang C; Bai Y; Li Y; Kang X; Chen JX; Yao K; Jiang T; Zhong XS; Li WB
Drug Des Devel Ther; 2017; 11():1905-1915. PubMed ID: 28721010
[TBL] [Abstract][Full Text] [Related]
20. miR‑24 regulates angiogenesis in gliomas.
Dai D; Huang W; Lu Q; Chen H; Liu J; Hong B
Mol Med Rep; 2018 Jul; 18(1):358-368. PubMed ID: 29749450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
